Final results regarding the addition of dendritic cell vaccines to neoadjuvant chemotherapy in early HER2-negative breast cancer patients Total responses CONTACT US Summary The purpose of this study is [...]
A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer Change in expression CONTACT US Summary In recurrent ovarian and [...]
Efficacy analysis of triple-negative breast cancer patients treated with dendritic cell-cytokine-induced killer cell immunotherapy Overall Survival CONTACT US Summary The study investigates the efficacy of dendritic cell-cytokine-induced killer (DC-CIK) [...]
Adjuvant treatment for triple-negative breast cancer: a retrospective study of immunotherapy with autologous cytokine- induced killer cells in 294 patients CIK treatment CONTACT US Summary The study aims to [...]
Hyperthermia and radiation therapy for locally advanced or recurrent breast cancer Overall Survival CONTACT US Summary This study aims to investigate the result and toxicity of combined hyperthermia [...]
Clinical Study of Modulated Electro‐Hyperthermia for Advanced Metastatic Breast Cancer CT scan CONTACT US Summary The present study aims to demonstrate the result of Modulated electro-hyperthermia [...]
Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse Cancers Overall Survival CONTACT US Summary This study investigates the correlation of cytokines produced [...]
A phase-1/2 study of adenovirus-p53 transduced Dendritic Cell Vaccine in combination with Indoximod in metastatic solid tumors and invasive Breast Cancer Survival rate CONTACT US Summary [...]
The impact of positive stimuli on breast cancer patients The impact of positive stimuli on breast cancer patients CONTACT US Summary The study conducted by the university [...]
Autologous dendritic cells and activated cytotoxic T‐cells as combination therapy for breast cancer Cytotoxicity against MCF-7 CONTACT US Summary Breast cancer is the most common oncological pathology in [...]
The future of cancer health, available now.
© Copyright 2022 | All rights reserved. © Immucura
